Localisation Policies To Hinder Pharmaceutical Growth Opportunities In Indonesia
Pharma & Healthcare / Indonesia / Fri 05 Oct, 2018
Key View
- The importance of Indonesia as an emerging market opportunity for multinational pharmaceutical firms will remain over the coming years.
- Protectionist policies employed in Indonesia will however pose challenges to drugmakers.
- Domestic pharmaceutical firms to present significant competition.
Forecasts
As the largest medicine market